Geode Capital Management, LLC
- SEC CIK
- 0001214717
- Latest filing
- Aug 12, 2026
CLDI holding history
Calidi Biotherapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDI overviewAll 13F holders of CLDIFull Q2 2026 holdings
- Shares (Q2 2026)
- 114,550
- Value
- $19.5K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 114,550 | $19.5K | <0.1% | +51,531+81.8% | Added | Holders |
| Q1 2026 | 63,019 | $15.0K | <0.1% | +21,090+50.3% | Added | Holders |
| Q4 2025 | 41,929 | $49.1K | <0.1% | +12,334+41.7% | Added | Holders |
| Q3 2025 | 29,595 | $45.0K | <0.1% | +10,214+52.7% | AddedConverted for a 1-for-12 split | Holders |
| Q2 2025 | 232,576 | $53.5K | <0.1% | −19,340−7.7% | Reduced | Holders |
| Q1 2025 | 251,916 | $142.6K | <0.1% | +91,898+57.4% | Added | Holders |
| Q4 2024 | 160,018 | $184.0K | <0.1% | +120,406+304.0% | Added | Holders |
| Q3 2024 | 39,612 | $45.2K | <0.1% | +39,612 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −107,110−100.0% | Sold out | Holders |
| Q1 2024 | 107,110 | $60.5K | <0.1% | +4,872+4.8% | Added | Holders |
| Q4 2023 | 102,238 | $154.4K | <0.1% | +102,238 | New | Holders |